These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16642755)

  • 21. Application of ecopathological methods to the investigation of health problems on farms.
    Fourichon C
    Rev Sci Tech; 1991 Mar; 10(1):151-77. PubMed ID: 1760571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presentation of economic evaluation results.
    Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S66-73. PubMed ID: 19253489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decision-analytical modelling in health-care economic evaluations.
    Sun X; Faunce T
    Eur J Health Econ; 2008 Nov; 9(4):313-23. PubMed ID: 17943332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A conceptual framework for economic optimization of single hazard surveillance in livestock production chains.
    Guo X; Claassen GD; Oude Lansink AG; Saatkamp HW
    Prev Vet Med; 2014 Jun; 114(3-4):188-200. PubMed ID: 24630402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Except in the South.
    Thomas S
    Appl Health Econ Health Policy; 2003; 2(3):128-9. PubMed ID: 14984276
    [No Abstract]   [Full Text] [Related]  

  • 26. Economic evaluation for ophthalmologists.
    Kuper H; Jofre-Bonet M; Gilbert C
    Ophthalmic Epidemiol; 2006 Dec; 13(6):393-401. PubMed ID: 17169853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should we use models to inform policy development?
    Guitian J; Pfeiffer D
    Vet J; 2006 Nov; 172(3):393-5. PubMed ID: 16707265
    [No Abstract]   [Full Text] [Related]  

  • 28. [The non-vaccination policy in economic perspective].
    Dijkhuizen AA
    Tijdschr Diergeneeskd; 1999 Feb; 124(3):84-6. PubMed ID: 10028146
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of management practices for the control of anthrax in animals: the 2005 anthrax epizootic in North Dakota--case study.
    Ndiva Mongoh M; Dyer NW; Stoltenow CL; Hearne R; Khaitsa ML
    Zoonoses Public Health; 2008 Aug; 55(6):279-90. PubMed ID: 18489538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of animal health compensation on 'positive' behaviours towards exotic disease reporting and implementing biosecurity: A review, a synthesis and a research agenda.
    Barnes AP; Moxey AP; Vosough Ahmadi B; Borthwick FA
    Prev Vet Med; 2015 Nov; 122(1-2):42-52. PubMed ID: 26422364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nature of animal health economics in relation to veterinary epidemiology.
    Mlangwa JE; Samui KL
    Rev Sci Tech; 1996 Sep; 15(3):797-812. PubMed ID: 9025136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National animal health surveillance: Return on investment.
    Scott AE; Forsythe KW; Johnson CL
    Prev Vet Med; 2012 Aug; 105(4):265-70. PubMed ID: 22305661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.
    Hubben GA; Bos JM; Glynn DM; van der Ende A; van Alphen L; Postma MJ
    Vaccine; 2007 May; 25(18):3669-78. PubMed ID: 17360082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic valuation through cost-benefit analysis--possibilities and limitations.
    Hansjürgens B
    Toxicology; 2004 Dec; 205(3):241-52. PubMed ID: 15464633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The benefit-cost analysis of disease control programs.
    Erb HN
    Vet Clin North Am Food Anim Pract; 1988 Mar; 4(1):169-81. PubMed ID: 3130972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of vector control techniques: an economic approach].
    Audibert M
    Med Trop (Mars); 2009 Apr; 69(2):185-93. PubMed ID: 19545044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments.
    Kobelt G; Jönsson B
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():95-106. PubMed ID: 18157559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodological issues in the economic analysis of cancer treatments.
    Tappenden P; Chilcott J; Ward S; Eggington S; Hind D; Hummel S
    Eur J Cancer; 2006 Nov; 42(17):2867-75. PubMed ID: 17023160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases.
    Kymes SM
    Ophthalmic Epidemiol; 2008; 15(2):76-83. PubMed ID: 18432490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Public health policy decisions on medical innovations: what role can early economic evaluation play?
    Hartz S; John J
    Health Policy; 2009 Feb; 89(2):184-92. PubMed ID: 18619704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.